TrialCancer medicine2022

Anlotinib for patients with small cell lung cancer and baseline liver metastases: A post hoc analysis of the ALTER 1202 trial.

Ying Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.